Skip to main content

Table 2 Effects of increasing dietary fibre intakes on cardiometabolic risk factors in patients with established CVD

From: Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses

Outcome Trials Participants (I/C) Initial I2 MD (95% CI) Grade
Total cholesterol (mmol/L) 3 117/110 99% − 0.42 (− 0.78 to − 0.05) Low
LDL cholesterol (mmol/L) 3 117/110 99% − 0.47 (− 0.85 to − 0.10) Low
HDL cholesterol (mmol/L) 3 117/110 99% 0.08 (− 0.02 to 0.17) Low
Triglycerides (mmol/L) 3 117/110 91% − 0.03 (− 0.15 to 0.08) Low
Systolic blood pressure (mmHg) 1 38/38 - − 1.2 (− 2.0 to − 0.4) Very low
Diastolic blood pressure (mmHg) 1 38/38 - − 3.6 (− 4.0 to − 3.2) Very low
Body weight (kg) 1 61/53 - − 0.20 (− 0.37 to − 0.04) Very low
BMI (kg/m2) 2 99/91 98% − 0.30 (− 0.69 to 0.09) Low
Waist circumference (cm) 1 61/53 - − 0.5 (− 0.6 to − 0.4) Very low
Fasting plasma glucose (mmol/L) 2 99/91 100% − 1.23 (− 2.13 to − 0.33) Low
Fasting plasma insulin (pmol/L) 1 38/38 - − 10.8 (− 13.2 to − 8.4) Very low